Weight-based dosing of ondansetron administered before spinal anesthesia to reduce hypotension in cesarean section: A randomized controlled superiority trial
Phase 2
Completed
- Conditions
- HypotensionOndansetron, Hypotension, Spinal anesthesia, Cesarean section
- Registration Number
- TCTR20160323001
- Lead Sponsor
- Prince of Songkla University
- Brief Summary
Ondansetron 0.05 mg/kg or 0.1 mg/kg administered before spinal anesthesia did not reduce the incidence of hypotension in this study.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 215
Inclusion Criteria
Pregnancy
ASA classification I-II
Gestational age 37-42 weeks
Spinal anesthesia
Singleton pregnancy
no labor pain
normal EKG
Exclusion Criteria
Refused to spinal block
Hypertensive disorder of pregnancy
ondansetron allergy
Heart disease
Coagulation abnormal
Morbid obesity
Placenta previa or totalis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method